NervGen Pharma (TSE:NGEN) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
NervGen Pharma has introduced an ‘at-the-market’ equity program allowing the company to sell common shares through the TSX Venture Exchange to raise up to C$30 million. This program offers NervGen flexibility to secure additional financing for various corporate purposes, including research and development.
For further insights into TSE:NGEN stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Disney (NYSE:DIS) Cuts Stephanopoulos Pay Post-Trump Settlement
- Ford (NYSE:F) Quality Turns In Surprising Win
- Intel (NASDAQ:INTC) Narrows Down Altera Buyers
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
